desonide   Click here for help

GtoPdb Ligand ID: 7066

Synonyms: D-2083 | Desowen®
Approved drug Immunopharmacology Ligand
desonide is an approved drug (FDA (1972))
Compound class: Synthetic organic
Comment: Desonide is a corticosteroid.
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 6
Hydrogen bond donors 2
Rotatable bonds 2
Topological polar surface area 93.06
Molecular weight 416.22
XLogP 1.4
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES OCC(=O)C12OC(OC1CC1C2(C)CC(O)C2C1CCC1=CC(=O)C=CC21C)(C)C
Isomeric SMILES OCC(=O)[C@@]12OC(O[C@@H]1C[C@@H]1[C@]2(C)C[C@H](O)[C@H]2[C@H]1CCC1=CC(=O)C=C[C@]21C)(C)C
InChI InChI=1S/C24H32O6/c1-21(2)29-19-10-16-15-6-5-13-9-14(26)7-8-22(13,3)20(15)17(27)11-23(16,4)24(19,30-21)18(28)12-25/h7-9,15-17,19-20,25,27H,5-6,10-12H2,1-4H3/t15-,16-,17-,19+,20+,22-,23-,24+/m0/s1
InChI Key WBGKWQHBNHJJPZ-LECWWXJVSA-N

For advanced searching click here to open chemical structure editor

Similar Ligands Click here for help
withanone
Click here for ligand page
Targets
CoV 3C-like (main) protease
withaferin A
Click here for ligand page
Targets
CoV 3C-like (main) protease
absinthin
Click here for ligand page
Targets
TAS2R30; TAS2R46
luminamicin
Click here for ligand page
nodusmicin
Click here for ligand page
fluticasone furoate
Click here for ligand page
tonantzitlolone
Click here for ligand page
Targets
TRPC4; TRPC5
sonolisib
Click here for ligand page
fludroxycortide
Click here for ligand page
prednicarbate
Click here for ligand page
difluprednate
Click here for ligand page
Targets
Glucocorticoid receptor
ciclesonide
Click here for ligand page
Targets
Glucocorticoid receptor
ingenol mebutate
Click here for ligand page
Targets
protein kinase C alpha; protein kinase C beta; protein kinase C delta; protein kinase C epsilon; protein kinase C gamma
budesonide
Click here for ligand page
Targets
Glucocorticoid receptor; Mineralocorticoid receptor; Progesterone receptor
loteprednol etabonate
Click here for ligand page
fluticasone propionate
Click here for ligand page
Targets
Glucocorticoid receptor; Mineralocorticoid receptor; Progesterone receptor
fluocinonide
Click here for ligand page
Targets
Glucocorticoid receptor
fluocinolone acetonide
Click here for ligand page
Targets
Glucocorticoid receptor
flunisolide
Click here for ligand page
Targets
Glucocorticoid receptor
flumethasone pivalate
Click here for ligand page
diflorasone diacetate
Click here for ligand page
Targets
Glucocorticoid receptor
clobetasol propionate
Click here for ligand page
Targets
Glucocorticoid receptor
amcinonide
Click here for ligand page
wortmannin
Click here for ligand page
Targets
mechanistic target of rapamycin kinase; phosphatidylinositol 4-kinase alpha; phosphatidylinositol 4-kinase beta; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma; protein kinase, DNA-activated, catalytic subunit
beclometasone dipropionate
Click here for ligand page
Targets
ADGRG3
thapsigargin
Click here for ligand page
ginkgolide X
Click here for ligand page
Targets
glycine receptor α1 subunit; glycine receptor α2 subunit; glycine receptor β subunit
4α-PDH
Click here for ligand page
Targets
TRPV4
eplerenone
Click here for ligand page
Targets
Mineralocorticoid receptor
triamcinolone acetonide
Click here for ligand page
Targets
Glucocorticoid receptor
correolide
Click here for ligand page
Targets
Kv1.3
bisandrographolide
Click here for ligand page
Targets
TRPV4
4α-PDD
Click here for ligand page
Targets
TRPV4
ivermectin
Click here for ligand page
Targets
Glycine Receptor (All subtypes); P2X4; P2X7; nicotinic acetylcholine receptor α7 subunit
phorbol 12-myristate 13-acetate
Click here for ligand page
Targets
KNa1.1; KNa1.2; Kir3.4; TRPV4
tetronothiodin
Click here for ligand page
Targets
CCK2 receptor